527 related articles for article (PubMed ID: 27693678)
1. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers.
Rubbens J; Brouwers J; Tack J; Augustijns P
Eur J Pharm Biopharm; 2016 Dec; 109():122-129. PubMed ID: 27693678
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal Behavior of Weakly Acidic BCS Class II Drugs in Man--Case Study of Diclofenac Potassium.
Van Den Abeele J; Brouwers J; Mattheus R; Tack J; Augustijns P
J Pharm Sci; 2016 Feb; 105(2):687-696. PubMed ID: 26375734
[TBL] [Abstract][Full Text] [Related]
3. Exploring the impact of real-life dosing conditions on intraluminal and systemic concentrations of atazanavir in parallel with gastric motility recording in healthy subjects.
Hens B; Masuy I; Deloose E; Mols R; Tack J; Augustijns P
Eur J Pharm Biopharm; 2020 May; 150():66-76. PubMed ID: 32113916
[TBL] [Abstract][Full Text] [Related]
4. Parallel monitoring of plasma and intraluminal drug concentrations in man after oral administration of fosamprenavir in the fasted and fed state.
Brouwers J; Tack J; Augustijns P
Pharm Res; 2007 Oct; 24(10):1862-9. PubMed ID: 17443397
[TBL] [Abstract][Full Text] [Related]
5. Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum.
Mitra A; Fadda HM
Mol Pharm; 2014 Aug; 11(8):2835-44. PubMed ID: 25025699
[TBL] [Abstract][Full Text] [Related]
6. Exploring food effects on indinavir absorption with human intestinal fluids in the mouse intestine.
Holmstock N; De Bruyn T; Bevernage J; Annaert P; Mols R; Tack J; Augustijns P
Eur J Pharm Sci; 2013 Apr; 49(1):27-32. PubMed ID: 23402972
[TBL] [Abstract][Full Text] [Related]
7. Biorelevant dissolution testing of a weak base: Interlaboratory reproducibility and investigation of parameters controlling in vitro precipitation.
Berben P; Ashworth L; Beato S; Bevernage J; Bruel JL; Butler J; Dressman J; Schäfer K; Hutchins P; Klumpp L; Mann J; Nicolai J; Ojala K; Patel S; Powell S; Rosenblatt K; Tomaszewska I; Williams J; Augustijns P
Eur J Pharm Biopharm; 2019 Jul; 140():141-148. PubMed ID: 31051249
[TBL] [Abstract][Full Text] [Related]
8. Meal composition effects on the oral bioavailability of indinavir in HIV-infected patients.
Carver PL; Fleisher D; Zhou SY; Kaul D; Kazanjian P; Li C
Pharm Res; 1999 May; 16(5):718-24. PubMed ID: 10350016
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Dissolution and Systemic Absorption of Immediate Release Ibuprofen in Human Gastrointestinal Tract under Fed and Fasted Conditions.
Koenigsknecht MJ; Baker JR; Wen B; Frances A; Zhang H; Yu A; Zhao T; Tsume Y; Pai MP; Bleske BE; Zhang X; Lionberger R; Lee A; Amidon GL; Hasler WL; Sun D
Mol Pharm; 2017 Dec; 14(12):4295-4304. PubMed ID: 28937221
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal and Systemic Monitoring of Posaconazole in Humans After Fasted and Fed State Administration of a Solid Dispersion.
Hens B; Corsetti M; Brouwers J; Augustijns P
J Pharm Sci; 2016 Sep; 105(9):2904-2912. PubMed ID: 27178739
[TBL] [Abstract][Full Text] [Related]
11. Supersaturation and Precipitation of Posaconazole Upon Entry in the Upper Small Intestine in Humans.
Hens B; Brouwers J; Corsetti M; Augustijns P
J Pharm Sci; 2016 Sep; 105(9):2677-2684. PubMed ID: 26505884
[TBL] [Abstract][Full Text] [Related]
12. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
[TBL] [Abstract][Full Text] [Related]
13. In vivo evaluation of supersaturation/precipitation/re-dissolution behavior of cinnarizine, a lipophilic weak base, in the gastrointestinal tract: the key process of oral absorption.
Tanaka Y; Kawakami A; Nanimatsu A; Horio M; Matsuoka J; Wada T; Kasaoka S; Yoshikawa H
Eur J Pharm Sci; 2017 Jan; 96():464-471. PubMed ID: 27773836
[TBL] [Abstract][Full Text] [Related]
14. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors.
Madsen CM; Boyd B; Rades T; Müllertz A
Eur J Pharm Sci; 2016 Aug; 91():31-9. PubMed ID: 27260089
[TBL] [Abstract][Full Text] [Related]
15. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
Shono Y; Jantratid E; Dressman JB
Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal and Systemic Disposition of Diclofenac under Fasted and Fed State Conditions Supporting the Evaluation of in Vitro Predictive Tools.
Van Den Abeele J; Schilderink R; Schneider F; Mols R; Minekus M; Weitschies W; Brouwers J; Tack J; Augustijns P
Mol Pharm; 2017 Dec; 14(12):4220-4232. PubMed ID: 28621952
[TBL] [Abstract][Full Text] [Related]
17. Gastric and Duodenal Diclofenac Concentrations in Healthy Volunteers after Intake of the FDA Standard Meal: In Vivo Observations and in Vitro Explorations.
Rubbens J; Brouwers J; Tack J; Augustijns P
Mol Pharm; 2019 Feb; 16(2):573-582. PubMed ID: 30571131
[TBL] [Abstract][Full Text] [Related]
18. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast.
Schug BS; Brendel E; Chantraine E; Wolf D; Martin W; Schall R; Blume HH
Br J Clin Pharmacol; 2002 Jun; 53(6):582-8. PubMed ID: 12047482
[TBL] [Abstract][Full Text] [Related]
19. Impact of food and the proton pump inhibitor rabeprazole on the pharmacokinetics of GDC-0941 in healthy volunteers: bench to bedside investigation of pH-dependent solubility.
Ware JA; Dalziel G; Jin JY; Pellett JD; Smelick GS; West DA; Salphati L; Ding X; Sutton R; Fridyland J; Dresser MJ; Morrisson G; Holden SN
Mol Pharm; 2013 Nov; 10(11):4074-81. PubMed ID: 24099279
[TBL] [Abstract][Full Text] [Related]
20. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
